Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Visor

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Pharmaceutical Research|June 1, 1994
Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeysK C Cundy, J A Fishback, J P Shaw, et al.
Lymphokine Research|January 1, 1990
Development and characterization of a lyophilized dosage form of IL-1 betaG C Visor, K P Tsai, M D Miller, et al.
Pharmaceutical Research|April 1, 1991
Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implicationsL C Gu, E A Erdös, H S Chiang, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Pharmaceutical Research|June 1, 1994
Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeysK C Cundy, J A Fishback, J P Shaw, et al.
Lymphokine Research|January 1, 1990
Development and characterization of a lyophilized dosage form of IL-1 betaG C Visor, K P Tsai, M D Miller, et al.
Pharmaceutical Research|April 1, 1991
Stability of interleukin 1 beta (IL-1 beta) in aqueous solution: analytical methods, kinetics, products, and solution formulation implicationsL C Gu, E A Erdös, H S Chiang, et al.
Pageof 3